IQVIA Holdings (LTS:0JDM) Valuation Rank


LTS:0JDM IQVIA Holdings Inc LTS:0JDM
87 GF Score
Price $203.41
GF Value $249.57
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

IQVIA Holdings Valuation Rank Related Terms

LTS:0JDM
87GF Score
IQVIA Holdings Inc LTS:0JDM
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IQVIA Holdings (LTS:0JDM) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of $203.41 is trading 18.5% below its estimated GF Value™ of $249.57. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for LTS:0JDM:

  • Valuation Rank:
  • GF Value™: $249.57 vs. price of $203.41 (18.5% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the LTS:0JDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
87GF Score

Get the complete analysis for LTS:0JDM

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$203.41
Price
$249.57
GF Value